Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youli Zu

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Blood|June 26, 2020
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myelomaQiang Wang, Dongyu Zhao, Miao Xian, et al.
Nature Communications|July 9, 2024
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasisMiao Xian, Qiang Wang, Liuling Xiao, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Molecular Pharmaceutics|March 15, 2018
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow InvolvementJunhua Mai, Xin Li, Guodong Zhang, et al.
European Journal of Haematology|June 15, 2020
High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemiaLina Wu, Miaoran Xia, Xiaoping Sun, et al.
Blood|August 19, 2021
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathwayQiang Wang, Zhijuan Lin, Zhuo Wang, et al.
Theranostics|January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor CellsHaoran Liu, Junhua Mai, Jianliang Shen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting Endothelial PERK Accelerates Lymphoid Regeneration by Enhancing DLL4-NOTCH3 Signaling at the Pre-B NicheBingqing Zou, Qiuyun Chen, Junjun Zheng, et al.
Nature Communications|June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaLing Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|July 7, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Blood|June 26, 2020
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myelomaQiang Wang, Dongyu Zhao, Miao Xian, et al.
Nature Communications|July 9, 2024
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasisMiao Xian, Qiang Wang, Liuling Xiao, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Molecular Pharmaceutics|March 15, 2018
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow InvolvementJunhua Mai, Xin Li, Guodong Zhang, et al.
European Journal of Haematology|June 15, 2020
High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemiaLina Wu, Miaoran Xia, Xiaoping Sun, et al.
Blood|August 19, 2021
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathwayQiang Wang, Zhijuan Lin, Zhuo Wang, et al.
Theranostics|January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor CellsHaoran Liu, Junhua Mai, Jianliang Shen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting Endothelial PERK Accelerates Lymphoid Regeneration by Enhancing DLL4-NOTCH3 Signaling at the Pre-B NicheBingqing Zou, Qiuyun Chen, Junjun Zheng, et al.
Nature Communications|June 28, 2022
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaLing Tao, Mahmoud A Mohammad, Giorgio Milazzo, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|July 7, 2021
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell InfectionXiaohui Liu, Yi-Ling Wang, Jacky Wu, et al.
Pageof 14